Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 4Pancreatic Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Colorectal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Anus Neoplasms 2Tongue Neoplasms 1Sinonasal undifferentiated carcinoma 1Salivary Gland Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Adenocarcinoma 1PRETEXT I Hepatoblastoma 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Klatskin Tumor 1Keratosis, Actinic 1Hypopharyngeal Neoplasms 1Hepatoblastoma 1HIV Infections 1Gallbladder Neoplasms 1Fibrolamellar hepatocellular carcinoma 1Epstein-Barr Virus Infections 1DNA Repair-Deficiency Disorders 1Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

dehydroftorafur 1Radiotherapy 1Radiation 1Platinum 1Fluorouracil 1Docetaxel 1Cisplatin 1Chemoradiotherapy 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Sinonasal undifferentiated carcinoma × dehydroftorafur × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡